20 Patents
- US124586522025Pharmaceutical Compositions of Spironolactone for Deep Dermal Drug Delivery
ARCUTIS BIOTHERAPEUTICS, Inc.
0 cites - 0 cites
- US123904532025Method for Reducing Side Effects from Administration of Phosphodiesterase-4 Inhibitors
ARCUTIS BIOTHERAPEUTICS, Inc.
0 cites - 0 cites
- US123297512025Topical Roflumilast Formulation Having Antifungal Properties
ARCUTIS BIOTHERAPEUTICS, Inc.
0 cites - US123109562025Topical Roflumilast Formulation Having Improved Delivery and Plasma Half-life
ARCUTIS BIOTHERAPEUTICS, Inc.
0 cites - 0 cites
- US121448022024Pharmaceutical Compositions of Roflumilast and Solvents Capable of Dissolving High Amounts of the Drug
ARCUTIS BIOTHERAPEUTICS, Inc.
0 cites - 0 cites
- 0 cites
- US120424872024Method for Reducing Side Effects from Administration of Phosphodiesterase-4 Inhibitors
ARCUTIS BIOTHERAPEUTICS, Inc.
0 cites - US120425582024Method and Formulation for Improving Roflumilast Skin Penetration Lag Time
ARCUTIS BIOTHERAPEUTICS, Inc.
0 cites - US120050512024Topical Roflumilast Formulation Having Improved Delivery and Plasma Half Life
ARCUTIS BIOTHERAPEUTICS, Inc.
0 cites - US120050522024Topical Roflumilast Formulation Having Improved Delivery and Plasma Half-life
ARCUTIS BIOTHERAPEUTICS, Inc.
0 cites - US119924802024Method for Reducing Side Effects from Administration of Phosphodiesterase-4 Inhibitors
ARCUTIS BIOTHERAPEUTICS, Inc.
0 cites - US118194962023Topical Roflumilast Formulation Having Improved Delivery and Plasma Half-life
Arcutis Biotherapeutics, Inc.
0 cites - 0 cites
- 0 cites
- US117074542023Topical Roflumilast Formulation Having Antifungal Properties
Arcutis Biotherapeutics, Inc.
0 cites - 0 cites